Item 8.01 - Other Events

On May 6, 2021 Daxor Corporation (the "Company") issued a press release announcing the Company received National Institute of Health (NIH) funding notification for a landmark multi-center heart failure trial utilizing the BVA-100® (Blood Volume Analyzer) with the United States Department of Veterans Affairs. The press release issued is attached to this filing as Exhibit 99.1





Item 9.01 Exhibits



(d) Exhibits. The following exhibit is filed with this Current Report on Form
8-K:



No.    Description
99.1     Press release dated May 6, 2021 - Daxor Corporation Receives National
       Institutes of Health (NIH) Funding Notification for Landmark Multi-Center
       Heart Failure Trial Utilizing the BVA-100® (Blood Volume Analyzer) with the
       United States Department of Veterans Affairs

© Edgar Online, source Glimpses